Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Small form factor flow virometer for SARS-CoV-2.
Hussain R, Ongaro AE, Rodriguez de la Concepción ML, Wajs E, Riveira-Muñoz E, Ballana E, Blanco J, Toledo R, Chamorro A, Massanella M, Mateu L, Grau E, Clotet B, Carrillo J, Pruneri V. Hussain R, et al. Among authors: mateu l. Biomed Opt Express. 2022 Feb 22;13(3):1609-1619. doi: 10.1364/BOE.450212. eCollection 2022 Mar 1. Biomed Opt Express. 2022. PMID: 35415002 Free PMC article.
Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses.
Alonso-Navarro R, Ramírez M, Masiá M, Paredes R, Montejano R, Povar-Echeverria M, Carratalà J, Salavert M, Bernal E, Dueñas C, Flores J, Fanjul F, Gutiérrez I, Rico V, Mateu L, Cadiñanos J, Berenguer J, Soriano A. Alonso-Navarro R, et al. Among authors: mateu l. BMC Infect Dis. 2023 May 4;23(1):286. doi: 10.1186/s12879-023-08222-y. BMC Infect Dis. 2023. PMID: 37142994 Free PMC article.
Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19.
Arber N, Shah PL, Assoumou L, Rokx C, De Castro N, Bakhai A, Soriano Viladomiu A, Mateu L, Lumbreras C, Estrada V, Curran A, Sellier PO, Duffy A, Fletcher C, Mozaffari E, Haubrich R, Hodgkins P, Pozniak A, Raffi F. Arber N, et al. Among authors: mateu l. Infect Dis Now. 2023 Oct;53(7):104760. doi: 10.1016/j.idnow.2023.104760. Epub 2023 Jul 14. Infect Dis Now. 2023. PMID: 37454762
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.
Mitjà O, Corbacho-Monné M, Ubals M, Alemany A, Suñer C, Tebé C, Tobias A, Peñafiel J, Ballana E, Pérez CA, Admella P, Riera-Martí N, Laporte P, Mitjà J, Clua M, Bertran L, Sarquella M, Gavilán S, Ara J, Argimon JM, Cuatrecasas G, Cañadas P, Elizalde-Torrent A, Fabregat R, Farré M, Forcada A, Flores-Mateo G, López C, Muntada E, Nadal N, Narejos S, Nieto A, Prat N, Puig J, Quiñones C, Ramírez-Viaplana F, Reyes-Urueña J, Riveira-Muñoz E, Ruiz L, Sanz S, Sentís A, Sierra A, Velasco C, Vivanco-Hidalgo RM, Zamora J, Casabona J, Vall-Mayans M, González-Beiras C, Clotet B; BCN-PEP-CoV2 Research Group. Mitjà O, et al. N Engl J Med. 2021 Feb 4;384(5):417-427. doi: 10.1056/NEJMoa2021801. Epub 2020 Nov 24. N Engl J Med. 2021. PMID: 33289973 Free PMC article. Clinical Trial.
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.
Trinité B, Tarrés-Freixas F, Rodon J, Pradenas E, Urrea V, Marfil S, Rodríguez de la Concepción ML, Ávila-Nieto C, Aguilar-Gurrieri C, Barajas A, Ortiz R, Paredes R, Mateu L, Valencia A, Guallar V, Ruiz L, Grau E, Massanella M, Puig J, Chamorro A, Izquierdo-Useros N, Segalés J, Clotet B, Carrillo J, Vergara-Alert J, Blanco J. Trinité B, et al. Among authors: mateu l. Sci Rep. 2021 Jan 28;11(1):2608. doi: 10.1038/s41598-021-81862-9. Sci Rep. 2021. PMID: 33510275 Free PMC article.
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes.
Pradenas E, Trinité B, Urrea V, Marfil S, Ávila-Nieto C, Rodríguez de la Concepción ML, Tarrés-Freixas F, Pérez-Yanes S, Rovirosa C, Ainsua-Enrich E, Rodon J, Vergara-Alert J, Segalés J, Guallar V, Valencia A, Izquierdo-Useros N, Paredes R, Mateu L, Chamorro A, Massanella M, Carrillo J, Clotet B, Blanco J. Pradenas E, et al. Among authors: mateu l. Med. 2021 Mar 12;2(3):313-320.e4. doi: 10.1016/j.medj.2021.01.005. Epub 2021 Jan 31. Med. 2021. PMID: 33554155 Free PMC article.
Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.
Rodon J, Muñoz-Basagoiti J, Perez-Zsolt D, Noguera-Julian M, Paredes R, Mateu L, Quiñones C, Perez C, Erkizia I, Blanco I, Valencia A, Guallar V, Carrillo J, Blanco J, Segalés J, Clotet B, Vergara-Alert J, Izquierdo-Useros N. Rodon J, et al. Among authors: mateu l. Front Pharmacol. 2021 Mar 25;12:646676. doi: 10.3389/fphar.2021.646676. eCollection 2021. Front Pharmacol. 2021. PMID: 33841165 Free PMC article.
High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients.
Rodríguez de la Concepción ML, Ainsua-Enrich E, Reynaga E, Ávila-Nieto C, Santos JR, Roure S, Mateu L, Paredes R, Puig J, Jimenez JM, Izquierdo-Useros N, Clotet B, Pedro-Botet ML, Carrillo J. Rodríguez de la Concepción ML, et al. Among authors: mateu l. Life Sci Alliance. 2021 Jul 28;4(9):e202001009. doi: 10.26508/lsa.202001009. Print 2021 Sep. Life Sci Alliance. 2021. PMID: 34321327 Free PMC article.
Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Massanella M, Martin-Urda A, Mateu L, Marín T, Aldas I, Riveira-Muñoz E, Kipelainen A, Jiménez-Moyano E, Rodriguez de la Concepción ML, Avila-Nieto C, Trinité B, Pradenas E, Rodon J, Marfil S, Parera M, Carrillo J, Blanco J, Prado JG, Ballana E, Vergara-Alert J, Segalés J, Noguera-Julian M, Masabeu À, Clotet B, Toda MR, Paredes R. Massanella M, et al. Among authors: mateu l. Open Forum Infect Dis. 2021 Jun 23;8(7):ofab329. doi: 10.1093/ofid/ofab329. eCollection 2021 Jul. Open Forum Infect Dis. 2021. PMID: 34337095 Free PMC article.
146 results